22nd Century Group Inc. is a leading plant biotechnology company focused on developing and commercializing genetically modified tobacco plants. The company’s proprietary technology enables the manufacture of reduced-nicotine and potentially non-addictive tobacco products. Their innovative approach aligns with the growing global demand for reduced-risk tobacco alternatives.
